Roadmap of the Pathways for Combination Medical Products

Combination products are therapeutic and diagnostic products that combine drugs, devices, and/or biological products. The roles of each component can result in varying regulatory procedures and research methods for the combined products. This webinar will bridge the gap between the pathways taken for combination products, including companion diagnostics, which are evaluated as drugs, medical devices, or both.
The objective of the webinar to explore the medical device and drug pathways for combination products. Participants will be able to:
• Identify combinations products and companion in vitro diagnostics
• Understand the varying regulatory pathways for combination products
• Evaluate real examples of research methods used to evaluate the safety and effectiveness of combination products

Components visible upon registration.